search icon

    Market Snapshot

    blog search icon

    Avenue Therapeutics, Inc. Stock Profile, Price, History

    Avenue Therapeutics, Inc.

    (NASDAQ:ATXI)

    $1.38

    0.00 (0.00%)

    At Close: 4:00 PM

    $1.4

    0.02 (1.45%)

    After Market: 9:02 PM

    Avenue Therapeutics, Inc.

    • 1D
    • 5D
    • 1M
    • 3M
    • 6M
    • 1Y
    • YTD
    • All

    ATXI Stock Price Today

    Avenue Therapeutics, Inc. (ATXI) stock declined over 0.00% intraday to trade at $1.38 a share on NASDAQ. The stock opened with a loss of -1.45% at $1.36 and touched an intraday high of $1.435, falling 0.00% against the last close of $1.38. The Avenue Therapeutics, Inc. in stock market went to a low of $1.34 during the session.

    Stock Snapshot

    $1.38

    Prev. Close

    7.4 Million

    Market Cap

    $1.34

    Day Low

    $1.36

    Open

    4.78 Million

    Number of Shares

    $1.435

    Day High

    -

    P/E ratio

    -3.66

    EPS (TTM)

    0.60

    Cash Flow per Share

    2.24

    Free Float in %

    0.14

    Book Value

    242,801

    Volume

    Contact Details

    1140 Avenue of the America
    9th Floor
    New York, NY 10036
    United States

    Website:https://www.avenuetx.com

    Contact #:781 652 4500

    Company Information

    Employees4

    Beta-0.53

    Sales or Revenue-

    5Y Sales Change-

    Fiscal Year EndsDec. 2021

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.

    Frequently Asked Questions

    icon

    What is the current Avenue Therapeutics, Inc. (ATXI) stock price?

    Avenue Therapeutics, Inc. (NASDAQ: ATXI) stock price is $1.38 in the last trading session. During the trading session, ATXI stock reached the peak price of $1.435 while $1.34 was the lowest point it dropped to. The percentage change in ATXI stock occurred in the recent session was 0.00% while the dollar amount for the price change in ATXI stock was $0.00.

    icon

    ATXI's industry and sector of operation?

    The NASDAQ listed ATXI is part of Pharmaceuticals industry that operates in the broader Health Care sector. Avenue Therapeutics, Inc. , a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting.

    icon

    Who are the executives of ATXI?

    Mr. David Jin
    Interim CEO & Principal Exec. Officer
    Dr. Lindsay Allan Rosenwald
    Exec. Chairman
    Dr. Xiaoqin Lu M.D.
    Consultant
    Dr. Alexandra MacLean M.D.
    Chief Exec. Officer

    icon

    How ATXI did perform over past 52-week?

    ATXI's closing price is 0.30% higher than its 52-week low of $1.06 where as its distance from 52-week high of $18.75 is -0.93%.

    icon

    How many employees does ATXI have?

    Number of ATXI employees currently stands at 4. ATXI operates from 1140 Avenue of the America, 9th Floor, New York, NY 10036, United States.

    icon

    Link for ATXI official website?

    Official Website of ATXI is: https://www.avenuetx.com

    icon

    How do I contact ATXI?

    ATXI could be contacted at phone #781 652 4500 and can also be accessed through its website. ATXI operates from 1140 Avenue of the America, 9th Floor, New York, NY 10036, United States.

    icon

    How many shares of ATXI are traded daily?

    ATXI stock volume for the day was 242,801 shares. The average number of ATXI shares traded daily for last 3 months was 940.31 Thousands.

    icon

    What is the market cap of ATXI currently?

    The market value of ATXI currently stands at $7.4 Million with its latest stock price at $1.38 and 4.78 Million of its shares outstanding.